← Back to all trials
Completed
NCT07308418
The Influence of Vibrotactile Stimulation on Self-selected Walking Speed in People With Parkinson's Disease
Conditions: Parkinson's Disease (PD)
Sex: All
Ages: 18 Years – N/A
Healthy volunteers: No
Phase: NA
Enrollment: 16
Sponsor: Magnes AG
Location: Magnes AG Zurich Canton of Zurich
Summary
The study tests whether a smart shoe (NUSHU) that provides vibrotactile stimulation can improve walking speed in people with Parkinson's disease. Sixteen participants complete two short walking tests-with and without vibration-to compare gait speed, cadence, stride length, usability, and safety. It is a low-risk pilot study meant to generate first evidence for future research.
Eligibility Criteria
Inclusion criteria:
* A medically confirmed diagnosis of Parkinson's disease on the physiotherapy prescription.
* Stable medication for at least four weeks (no change in dopaminergic therapy).
* The ability to walk at least 200 metres without stopping.
* Minimum age: 18 years
* Sufficient knowledge of German to understand the study information and complete the questionnaires.
* Written informed consent form
Exclusion criteria:
* Atypical or secondary Parkinsonism
* Sensory disturbances in the feet (e.g. polyneuropathy).
* Other neurological, orthopaedic or internal medical conditions that significantly affect walking
* Cognitive impairments that interfere with understanding the study information or following instructions
Source: ClinicalTrials.gov (NCT07308418). StuddyBuddy aggregates publicly available trial information.